Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
8pKH6UxqpeeAFGyU
Écouter
